alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT
31.1





SARBANES-OXLEY
SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER








I,
Russell W. Mitchell, Chief Executive Officer of PuraMed Bioscience Inc., certify
that:





1.           I
have reviewed this report on Form 10-Q of PuraMed Bioscience Inc.;





2.           Based
on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;





3.           Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the small business issuer as
of, and for, the periods presented in this report;





4.           The
small business issuer’s other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and
have:









a)           Designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material
information relating to the small business issuer, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;





b)           Evaluated
the effectiveness of the small business issuer’s disclosure controls and
procedures as of the end of the period covered by this report based on such
evaluation; and





c)           Disclosed
in this report any change in the small business issuer’s internal control over
financial reporting that occurred during the small business issuer’s most recent
fiscal quarter (the small business issuer’s fourth fiscal quarter in the case of
an annual report) that has materially affected, or is reasonably likely to
materially affect, the small business issuer’s internal control over financial
reporting; and





5.           The
small business issuer’s other certifying officer and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
small business issuer’s auditors and the audit committee of small business
issuer’s board of directors (or persons performing the equivalent
functions):





a)           All
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the small business issuer’s ability to record, process,
summarize and report financial information; and





b)           Any
fraud, whether or not material, that involves management or other employees who
have a significant role in the small business issuer’s internal control over
financial reporting.





Date:  February
17,
2009                                                       /s/ Russell W.
Mitchell


Russell W. Mitchell


Chairman and Chief Executive
Officer
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549



---

FORM 8-K

---



CURRENT REPORT



Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934



February 26, 2007 (February 20, 2007)

Date of Report (Date of earliest event reported)



---

AVAX TECHNOLOGIES, INC.

(Exact name of Registrant as specified in its charter)





Delaware
        000-29222
        13-3575874(State or other jurisdiction
of incorporation)
        (Commission File Number)
        (IRS Employer
Identification Number)




2000 Hamilton Street

Suite 204

Philadelphia, PA  19130

(Address of principal executive offices, including zip code)



(215) 241-9760

(Registrants telephone number, including area code)



---

Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:



oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).



oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).



oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).



oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).





---

Item 8.01
        Other Events.




On February 20, 2007, the Company issued a press release announcing a collaboration and production agreement with Cancer Treatment Centers of America, Inc. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference.



Item 9.01
        Financial Statements and Exhibits.




(d)
        Exhibits.




The following exhibit is filed with this report:




99.1
        AVAX Technologies, Inc. Press Release Issued February 20, 2007.






-1-

---



SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



AVAX TECHNOLOGIES, INC.Date:  February 26, 2007.
        
        By:
        /s/ Richard P. RaineyName:
        Richard P. RaineyTitle:
        President






-2-

---
IV 

111TH CONGRESS 

2D SESSION H. RES. 1056 

Expressing support for designation of April as National Limb Loss Awareness 

Month. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 2, 2010 

Mr. DUNCAN (for himself and Mr. FALEOMAVAEGA) submitted the following 

resolution; which was referred to the Committee on Energy and Commerce 

RESOLUTION 

Expressing support for designation of April as National Limb 

Loss Awareness Month. 

Whereas in the United States, there are approximately 

2,000,000 people living with limb loss; 

Whereas it is estimated that 1 out of every 200 people in the 

United States has had an amputation; 

Whereas there are 1,000 babies born each year with congenital limb loss; 

Whereas there are more than 185,000 new amputations performed each year in the United States; 

Whereas unless drastic preventative measures are undertaken 

to reduce the incidents of diabetic and vascular related 

diseases this number will increase; 


smartinez on DSKB9S0YB1PROD with BILLS
2 

•HRES 1056 IH 

Whereas it is vital to have access to preventative care for diabetes and peripheral vascular disease (PVD), to have 

weight management as part of all care plans, and to have 

safety information to prevent traumatic limb loss readily 

available; 

Whereas the Amputee Coalition of America provides education, outreach, advocacy, and a National Limb Loss Information Center for the benefit of persons with limb 

loss, their families, and health care providers; and 

Whereas April would be an appropriate month to designate 

as National Limb Loss Awareness Month: Now, therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) supports the designation of National Limb 

3 Loss Awareness Month; 

4 (2) encourages State legislatures and assemblies 

5 to issue proclamations designating National Limb 

6 Loss Awareness Month; 

7 (3) commends the efforts of the Amputee Coali8 tion of America and other entities and the people of 

9 the United States who support the goals and ideals 

10 of National Limb Loss Awareness Month; 

11 (4) recognizes and reaffirms the Nation’s com12 mitment to advancing health policies aimed at pre13 venting limb loss, promoting awareness about the 

14 causes of limb loss including limb deficiencies, and 

15 expanding access to devices, care, and rehabilitation 


smartinez on DSKB9S0YB1PROD with BILLS
3 

•HRES 1056 IH 

1 aimed at allowing people with limb loss to lead inde2 pendent, productive lives; and 

3 (5) recognizes all people in the United States 

4 living with limb loss, expresses gratitude to their 

5 family members and friends who are a source of love 

6 and encouragement to them, and salutes the health 

7 care professionals and medical researchers who pro8 vide assistance to those so afflicted and continue to 

9 work to prevent limb loss and improve follow-up care 

10 and rehabilitation outcomes. 

Æ 


smartinez on DSKB9S0YB1PROD with BILLS
<TABLE>
<CAPTION>


                                       EXHIBIT 12.1

                          WINSLOEW FURNITURE INC. AND SUBSIDIARIES
                      COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES


             Successor                          Predecessor
             Company                            Company
             Period        Period
             from August   from January
             27, 1999 to   1, 1999
             December 31,  to August 26,

                    1999    1999        1998        1997      1996     1995
                   -----  ---------   ------   ----------   -------   -------
  <S>               <C>        <C>         <C>        <C>         <C>        <C>
( In thousands )
Income Statement
 Data:
Income from
continuing
operations
before income
taxes and
extraordinary
items               $3,736  24,114    $29,247     $17,999    $13,377     $6,946

Add:
Interest expense     8,804     106        635       2,296      3,083      3,841
                    ------  -------   --------    --------   --------   -------
Earnings as
defined             12,540  24,220      29,882      20,295     16,460     10,787
  by agreement

Fixed charges

Interest expense
including
amortization
of debt
expensed             9,005     304         635       2,296      3,083      3,841

Ratio of
earnings to
fixed charges        1.39x     79.67x      47.1x       8.8x        5.3x      2.8x

</TABLE>
* Pursuant to 5TH CIR. R. 47.5, the court has determined that

this opinion should not be published and is not precedent except

under the limited circumstances set forth in 5TH CIR. R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

April 11, 2006

Charles R. Fulbruge III

Clerk

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 05-40609 

Conference Calendar

MICHAEL LYNN BRADDEN,

Plaintiff-Appellant,

versus

AUREL L. ADAMS; MURRY A. FUNDERBURG,

Defendants-Appellees.

--------------------

Appeal from the United States District Court

for the Eastern District of Texas

USDC No. 6:04-CV-462 

--------------------

Before JONES, Chief Judge, and JOLLY and DAVIS, Circuit Judges. 

PER CURIAM:*

Michael Lynn Bradden, Texas inmate No. 1171646, has appealed

the dismissal of his in forma pauperis (IFP) civil rights

complaint pursuant to 28 U.S.C. § 1915A(b). Section 1915A

directs the district court to dismiss sua sponte any frivolous

complaint filed by a prisoner against a “governmental entity or

officer or employee of a governmental entity.” 28 U.S.C. 

§ 1915A(b). A complaint is frivolous if it lacks an arguable
No. 05-40609

-2-

** The parties consented to proceed before a magistrate

judge pursuant to 28 U.S.C. § 636(c). 

basis in fact or if it is based on an indisputably meritless

legal theory. Berry v. Brady, 192 F.3d 504, 507 (5th Cir. 1999).

Bradden alleged that he was denied prescription medication

in deliberate indifference to his serious medical needs. The

magistrate judge** held that the complaint was frivolous because

Bradden’s claims lacked an arguable legal basis. Bradden has

failed to demonstrate that the defendants were deliberately

indifferent to a serious medical need or that the magistrate

judge erred by dismissing the complaint as frivolous. Velasquez

v. Woods, 329 F.3d 420, 421 (5th Cir. 2003); Domino v. Texas

Dep't of Criminal Justice, 239 F.3d 752, 756 (5th Cir. 2001). 

Accordingly, we affirm the dismissal of the complaint. 

The dismissal of the complaint and this court’s affirmance

of the dismissal count as one strike against Bradden for purposes

of 28 U.S.C. § 1915(g). See Adepegba v. Hammons, 103 F.3d 383,

387-88 (5th Cir. 1996). Bradden is warned that, should he

accumulate three strikes, he will be barred from proceeding IFP

in any civil action or appeal filed while he is incarcerated or

detained in any facility unless he is under imminent danger of

serious physical injury. See 28 U.S.C. § 1915(g). 

AFFIRMED; SANCTION WARNING ISSUED.
#### UNITED STATES of America, Plaintiff-Appellee, v. Anthony Lewis GLENN, Defendant-Appellant.

No. 09-7496.

United States Court of Appeals, Fourth Circuit.

Submitted: April 27, 2010.

Decided: May 11, 2010.

Anthony Lewis Glenn, Appellant Pro Se. Anne Margaret Hayes, Rudolf A. Renfer, Jr., Assistant United States Attorneys, Raleigh, North Carolina, for Appellee.

Before WILKINSON and NIEMEYER, Circuit Judges, and HAMILTON, Senior Circuit Judge.

Affirmed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Anthony Lewis Glenn appeals from the district court’s order granting his 18 U.S.C. § 3582 (2006) motion for a sentence reduction based upon the crack cocaine amendments to the Sentencing Guidelines. On appeal, Glenn asserts that, given the changes in law since he was originally sentenced, the court should have recalculated his Guidelines range without certain enhancements. However, “proceedings under § 3582(c)(2) do not constitute a full resentencing of the defendant.... Rather, § 3582(c)(2) and U.S.S.G. § 1B1.10 are narrow provisions that allow a limited reduction of sentence by the amount specified in an amendment, while prohibiting a complete reevaluation.” *United States v. Dunphy,*551 F.3d 247, 251-52 (4th Cir.) (internal quotation marks omitted), *cert. denied,*— U.S. -, 129 S.Ct. 2401, 173 L.Ed.2d 1296 (2009). In addition, the district court may only consider the effect of the retroactive amendment, not any other sentencing or Guidelines issues. *U.S. Sentencing Guidelines Manual*§ 1B1.10, p.s., comment, (n. 2) (2009). Accordingly, we affirm. We deny Glenn’s motion for appointment of counsel and dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED.*
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 874 Introduced in House (IH)]

111th CONGRESS
  1st Session
                                H. R. 874

          To allow travel between the United States and Cuba.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 4, 2009

 Mr. Delahunt (for himself, Mr. Flake, Ms. DeLauro, Mrs. Emerson, Mr. 
 McGovern, Mr. Moran of Kansas, Ms. Edwards of Maryland, Mr. Paul, and 
  Mr. Farr) introduced the following bill; which was referred to the 
                      Committee on Foreign Affairs

_______________________________________________________________________

                                 A BILL

 
          To allow travel between the United States and Cuba.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Freedom to Travel to Cuba Act''.

SEC. 2. TRAVEL TO CUBA.

    On and after the date of the enactment of this Act, and subject to 
section 3--
            (1) the President may not regulate or prohibit, directly or 
        indirectly, travel to or from Cuba by United States citizens or 
        legal residents, or any of the transactions incident to such 
        travel; and
            (2) any regulation in effect on such date of enactment that 
        regulates or prohibits travel to or from Cuba by United States 
        citizens or legal residents or transactions incident to such 
        travel shall cease to have any force or effect.

SEC. 3. EXCEPTIONS.

    Section 2 shall not apply in a case in which the United States is 
at war with Cuba, armed hostilities between the two countries are in 
progress, or there is imminent danger to the public health or the 
physical safety of United States travelers.

SEC. 4. APPLICABILITY.

    This Act applies to actions taken by the President before the date 
of the enactment of this Act that are in effect on such date of 
enactment, and to actions taken on or after such date.

SEC. 5. INAPPLICABILITY OF OTHER PROVISIONS.

    The provisions of this Act apply notwithstanding section 102(h) of 
the Cuban Liberty and Democratic Solidarity (LIBERTAD) Act of 1996 (22 
U.S.C. 6032(h)) and section 910(b) of the Trade Sanctions Reform and 
Export Enhancement Act of 2000 (22 U.S.C. 7210(b)).
                                 <all>
```
Exhibit
32.1





CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report of Homeland Resources Ltd. (the “Company”)
on Form 10-Q for the period ending April 30, 2009, as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Armando Garcia,
Chief Executive Officer and Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:





(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





Date:  June
5, 2009











/s/ Armando
Garcia  Armando
Garcia,


President,
Secretary & Treasurer


(principal
executive and financial officer)
---

EXHIBIT 32.2

|CERTIFICATION OF CHIEF FINANCIAL OFFICER     
|---------------------------------------------
|                                             
|PURSUANT TO                                  
|18 U.S.C. SECTION 1350,                      
|AS ADOPTED PURSUANT TO                       
|SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Theron Resource
Group. (the Company) on Form 10-Q for the quarter and six month period ended
November 30, 2010, as filed with the Securities and Exchange Commission on the
date hereof (the Periodic Report), I, Jerry R. Satchwell, Chief Financial
Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

|1. | the Periodic Report fully complies with the requirements
      of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
    and                                 
|-- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   |                                                                                                                                                                          
|2. | the information contained in the Periodic Report fairly
      presents, in all material respects, the financial condition and results of
      operations of the Company.

Date: January 21, 2011

/s/          
Jerry R. Satchwell

Jerry R. Satchwell Chief Financial
Officer

A signed original of this written statement required by Section
906, or other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to Theron Resource
Group. and will be retained by Theron Resource Group. and furnished to the
Securities and Exchange Commission or its staff upon request.

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Reserve System

      ( print page 30193)    
                    In accordance with § 271.5 of its rules regarding availability of information (12 CFR part 271), there is set forth below the domestic policy directive issued by the Federal Open Market Committee at its meeting held on March 20, 2001.[1] 

The Federal Open Market Committee seeks monetary and financial conditions that will foster price stability and promote sustainable growth in output.  To further its long-run objectives, the Committee in the immediate future seeks conditions in reserve markets consistent with reducing the federal funds rate to an average of around 5 percent.

By order of the Federal Open Market Committee, May 23, 2001.

Donald L. Kohn,

Secretary, Federal Open Market Committee.

# Footnotes

1.                             Copies of the Minutes of the Federal Open Market Committee meeting of March 20, 2001, which include the domestic policy directive issued at that meeting, are available upon request to the Board of Governors of the Federal Reserve System, Washington, D.C. 20551.  The minutes are published in the Federal Reserve Bulletin and in the Board's annual report.                    
        Back to Citation      

[FR Doc. 01-14054 Filed 6-4-01; 8:45 am]

BILLING CODE 6210-01-S
# Precious Metals - Charges

# Base Metals - Charges

# Precious-Depository Weighmaster

# Precious Metals - Assayers

# Precious Metals - Carriers

# Gold (GC) Brands

MKR03-31-17

MKR12-14-18

MKR07-31-20C

MKR03-07-22

# Gold (4GC) Brands

MKR03-31-17

MKR12-14-18

MKR03-07-22

# Gold Kilo (GCK) Brands

MKR12-14-18

MKR03-31-17

MKR03-07-22

# Silver (SI) Brands

MKR03-31-17

MKR12-14-18

MKR03-07-22

MKR07-18-22

# Platinum (PL) Brands

MKR04-08-22

# Palladium (PA) Brands

MKR04-08-22

# Base Warehouses Weighmasters

# Base Metal - Assayers

# Copper (HG) Brands

# Aluminum (ALI) Brands

# Zinc (ZNC) Brands

# Lead (LED) Brands

# ULSD & RBOB Gasoline Terminals